Downloads

  1. Expand Your T-Cell Research With Confidence 12/5/2025

    Achieve deeper T-cell characterization with a panel designed for flexibility. Streamline multicolor panel design, see higher resolution markers, and enable intracellular cytokine detection together.

  2. Biotech Wasn't Ready For AI's Speed; Here's How We Catch Up 12/5/2025

    Computational success is no stand-in for therapeutic readiness. Innovators must learn to discern between models rooted in science and those that speculate.

  3. Strained Manufacturing, Complexity Stymie In Vivo Progress 12/4/2025

     Explicitly mapping delivery challenges to the associated GMP process steps converts biological risk into operational risk.

  4. To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem 12/4/2025

    The choice of delivery dictates the complexity of manufacturing, which in turn determines the eventual cost and accessibility of the therapy.

  5. Is Oncology Precision Medicine Coming of Age? 12/3/2025

    Developers are releasing new data suggesting that their targeted therapy candidates may finally address some of oncology’s toughest challenges.

  6. CROs In Early Drug Discovery, Part 2: Keeping Pace And Protecting Quality 12/3/2025

    Part 2 of this series covers how to maintain momentum and protect data quality.

  7. Altasciences' State-Of-The-Art Research Facilities 12/2/2025

    With over 585,000-sq.-ft. of purpose-built space, our preclinical facilities across North America are designed to support your drug development journey, from early discovery to IND/NDA submission.

  8. NHP PK/PD Studies With Fast Start-Ups and Seamless Transition 12/2/2025

    Watch our latest video on how our Sacramento site accelerates NHP-based PK, PD, and biodistribution studies with streamlined access, expert teams, and dedicated facilities.

  9. The Blue Crayfish: Turning Nature's Efficiency Into Safe, Bioavailable Therapeutics 12/1/2025

    Crayfish achieve incredibly rapid biomineralization — a physiological marvel that is now setting the stage for a new class of highly bioavailable mineral-based therapeutic agents.

  10. CROs In Early Drug Discovery, Part 1: Choosing The Right Partner 11/26/2025

    Part 1 of this series covers how to choose the right CRO partner and establish clear scientific expectations along with a well-defined statement of work.